Jon Arnason

2PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Dec 20, 2024
Early versus late infectious complications following chimeric antigen receptor-modified T-cell therapy.

P Bindal, C A Trottier, P Elavalakanar

|Jul 27, 2022
Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy.

Matt Weinstock, Pavania Elavalakanar, Susan Bright

Pageof 1